Medix (TSE:331A) Revenue: 円4,459 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:331A Medix Inc TSE:331A
19 GF Score
Price 円490.00
! 4 Warning Signs
View Full Analysis

What is Medix Revenue?

Medix TSE:331A 19 Revenue is 円4,459 Mil as of Mar. 2026. GuruFocus rates TSE:331A with a GF Score™ of 19/100. The stock has 4 warning signs investors should review.

Medix's revenue for the three months ended in Mar. 2026 was 円1,258 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was 円4,459 Mil. Medix's Revenue per Share for the three months ended in Mar. 2026 was 円159.13. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円567.12.

Warning Sign:

Medix Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Medix was -2.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was -1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 4 years, Medix's highest 3-Year average Revenue per Share Growth Rate was -1.50% per year. The lowest was -1.50% per year. And the median was -1.50% per year.


Medix  (TSE:331A) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Medix Revenue Related Terms


Medix Revenue Historical Data

* Premium members only.

The historical data trend for Medix's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medix Revenue Chart

Medix Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Revenue
4,273.01 4,179.86 4,161.84 4,256.89

Medix Quarterly Data
Mar23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Revenue Get a 7-Day Free Trial Premium Member Only 961.25 975.95 1,062.05 1,257.63 1,163.26

TSE:331A vs APP, OMC, TTD: Revenue Comparison

For the Advertising Agencies subindustry, Medix's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medix Revenue vs Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, Medix's Revenue distribution charts can be found below:

* The bar in red indicates where Medix's Revenue falls into.


TSE:331A
19GF Score
Medix Inc TSE:331A
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medix Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円4,459 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of 円4,459 Mil mean?
Medix (TSE:331A) has a Revenue of 円4,459 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Medix and its competitors.
Is Medix's Revenue too high?
Medix's current Revenue is 円4,459 Mil. Overall, Medix has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medix's Revenue compare to APP and OMC?
Medix's Revenue of 円4,459 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Media - Diversified company?
A good Revenue depends on the Media - Diversified industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Medix and its competitors. Medix's current Revenue is 円4,459 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medix stock overvalued right now?
Medix (TSE:331A) has a current Revenue of 円4,459 Mil. The current Revenue is 円4,459 Mil. Medix's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Medix (TSE:331A), the current Revenue is 円4,459 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medix Business Description

Address 1-105 Kanda-Jinbo-cho, 19th Floor, Jimbocho Mitsui Building, Chiyoda-ku, Tokyo, JPN, 101-0051
Medix Inc is an internet advertising agency that places the utmost importance on understanding its clients' business models deeply and helping them solve problems over the medium to long term. It is engaged in Digital marketing services including creative design and production, data parsing and analysis, and Internet advertising services. The company provides services in the digital marketing field to clients in various lines and industries.
19GF Score

Get the complete analysis for TSE:331A

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円490.00
Price